Stéphane Nancey

8PUBLICATIONS
26CO-AUTHORS
Other European languagesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Cheminformatics and quantitative structure-activity relationshipsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 28, 2026
Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study.

|Aug 28, 2025
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.

Marie André, Julien Kirchgesner, David Laharie

|Jul 12, 2025
Advances in Understanding Intestinal Homeostasis: Lessons from Inflammatory Bowel Disease and Monogenic Intestinal Disorder Pathogenesis.

Céline Petit, Aurore Rozières, Gilles Boschetti

|Aug 09, 2024
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.

Bénédicte Caron, Philippe Seksik, Anthony Buisson

|May 11, 2024
Prevalence of the Oral Corticosteroid Exposure and Excessive Use in Patients with Inflammatory Bowel Disease: Data from Four French Referral Centers of the International DICE Study.

Stéphane Nancey, Xavier Hébuterne, Cyrielle Gilletta

|Apr 14, 2024
Impaired reprogramming of the autophagy flux in maturing dendritic cells from crohn disease patients with core autophagy gene-related polymorphisms.

Gaëlle Quiniou, Leslie Andromaque, Rémi Duclaux-Loras

Pageof 2

Frequent Collaborators

2 joint publications

David Laharie

2 joint publications

Laurent Peyrin-Biroulet

2 joint publications

Xavier Hébuterne

2 joint publications

Rémi Duclaux-Loras